Ascendis Pharma A (ASND) Change in Taxes (2014 - 2015)

Ascendis Pharma A (ASND) posted Change in Taxes of -$134586.5 for Q3 2015, down 109.97% sequentially from -$64098.2 in Q2 2015, and up 43.67% YoY from -$93679.4 in Q3 2014.

Ascendis Pharma A (ASND) Change in Taxes (2014 - 2015) Analysis & Trends

Ascendis Pharma A has reported Change in Taxes for 2 years, with the latest figure at -$134586.5 in Q3 2015.

  • Quarterly Change in Taxes rose 43.67% year-over-year to -$134586.5 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was -$990248.2 (changed N/A YoY) and the FY2014 annual result came in at -$1.1 million, down 234.61% from the prior year.
  • Change in Taxes eased to -$134586.5 in Q3 2015 per ASND's latest filing, from -$64098.2 in the prior quarter.
  • Over five years, Change in Taxes peaked at -$53444.3 in Q1 2014 and troughed at -$724903.4 in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Ascendis Pharma A 15.40 Bn 14.73 Bn 268.20 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2015 -134,586.47
Sep 30, 2015 -134,586.47
Jun 30, 2015 -64,098.19
Jun 30, 2015 -64,098.19
Mar 31, 2015 -66,660.12
Mar 31, 2015 -66,660.12
Dec 31, 2014 -724,903.42
Dec 31, 2014 -724,903.42
Sep 30, 2014 -238,912.46
Sep 30, 2014 -238,912.46
Mar 31, 2014 -53,444.25
Mar 31, 2014 -53,444.25